Summary: This article examines the legal framework in India relevant to misuse of corporate opportunities by directors and its implications for investors pursuing multiple opportunities. It also discusses reforms needed in Indian law and use of transaction documents to strengthen compliance and prevent misuse.
A corporate opportunity is a business opportunity closely related to a company’s business, of which a senior executive, such as a director, becomes aware by virtue of their designation. The corporate opportunity doctrine prevents conflicts between a director’s duty towards their company and their personal interests in opportunities arising from their directorial position, thereby preventing the misuse of any opportunity that “rightfully belongs” to the company for personal gain. However, determining what “rightfully belongs” to the company remains uncertain and requires frequent testing, particularly for nominees of financial sponsors such as private equity investors, family offices, and lenders (“Investors”), whose nominee directors may serve on the boards of multiple, and sometimes competing companies while maintaining personal external business interests.
Legal Framework in India
Section 166 of the Companies Act, 2013 (the “Act”) prescribes the “duties of directors”, requiring a director to “act in good faith” and “in the best interests of the company”. Section 166(4) of the Act prohibits a director from becoming involved in “a situation in which he may have a direct or indirect interest that conflicts, or possibly may conflict, with the interest of the company”. Section 166(5) further prohibits a director from achieving or attempting to achieve “any undue gain or advantage either to himself or his relatives, partners, or associates”. Section 184(1) requires that every director disclose their concern or interest in any company, body corporate, firm, or other association of individuals at the first board meeting of every financial year, or whenever there is any relevant change, by filing Form MBP-1. Section 184(2) prohibits an interested director from participating in the board meeting that discusses any contract or arrangement in which they are interested, and any participation in contravention renders the contract/arrangement voidable at the option of the company.
However, neither the substantive duties under Section 166 nor the procedural requirements under Section 184 adequately addresses the specific question of corporate opportunities. While Section 166 codifies the fiduciary obligations of the directors, such as good faith, avoidance of conflict, etc., the corporate opportunity doctrine is a narrower common law principle that addresses whether a director may divert or personally exploit a specific business opportunity that the company was capable of pursuing or had a legitimate interest in. Unlike jurisdictions that have codified this rule, in India this rule is still broadly construed under Section 166 and its contours remain to be clarified through judicial interpretation.
In Vaishnav Shorilal v. Kishore Sippy,[1]the managing group of a company diverted a business opportunity to another entity floated by them. Although the Bombay High Court acknowledged that this was hardly bona fide, it ruled in the managing group’s favour, reflecting the muddled application of the doctrine of corporate opportunity in India. Moreover, as there have not been many other instances of this being tested in Courts in India, uncertainty persists on what constitutes an “interest that conflicts”and when a director has been “directly or indirectly” involved in such situations, particularly if the undue gain or advantage is indirectly derived through a benefit to the nominating Investor.
This uncertainty also imposes a significant burden on Investors, who must conduct a fact-based analysis for each investment to determine that no corporate opportunity was misappropriated, leading to certain practical challenges. For example, an Investor focused on a particular sector may receive additional investment opportunities in that sector, but it would be unreasonable to require disclosure of each such opportunity. There is also no clarity on when the board must be informed, whether upon the opportunity arising or before its finalisation. Either timeline may disrupt the Investor’s business. An opportunity that is non-conflicting at the time it arises may become conflicting upon subsequent business expansion, creating retrospective implications and litigation risk. For instance, in OOPA Pte. Ltd. v. Bui Sy-Phong[2]before the Singapore High Court, a director incorporated a new entity and diverted a supply-chain business developed using the investee company’s resources. The court held that the director was “not entitled to conceal what he was doing, nor deal secretly with [the company’s] property as if it was his own”, underscoring the need for adequate ex ante disclosure mechanisms. Without certainty regarding the disclosure of opportunities, directors and Investors remain exposed to the legal uncertainty that their parallel pursuits may be treated as misappropriation of corporate property and opportunity, regardless of their subjective intent.
Investors holding board seats while pursuing similar investments face two options: (a) seek board consent for each opportunity on a case-by-case basis or (b) accept the legal and reputational risks. Neither option is practical in all situations, and both underscore the need for a more structured regulatory and contractual framework.
A Multi-Layered Framework for Protection of Investors and Nominee Directors
As Indian jurisprudence offers limited clarity, the following reforms merit consideration, While these have so far not been considered in the Corporate Laws (Amendment) Bill, 2026, each adds a further layer of flexibility for investments. Firstly, a clear ex post review framework should be introduced to provide greater certainty and confidence to Investors. Secondly, Sections 166(4) and 166(5) may be amended to resolve interpretative ambiguity by incorporating a multi-limb framework, which prevents a director from appropriating a business opportunity where (i) the corporation is financially able to exploit the opportunity; (ii) the opportunity is within the corporation’s line of business; (iii) the corporation has an interest or expectancy in the opportunity; and (iv) taking the opportunity for their own places the corporate fiduciary in a position inimical to their duties to the corporation. Thirdly, a timely statutory disclosure and cleansing mechanism under strict confidentiality safeguards could require disclosure of the nature and scope of the opportunity, its relationship to the company’s business, and the director’s direct or indirect interest in it. Although this does not entirely resolve the problem as opportunities offered under strict non-disclosure agreements may render disclosure legally impossible, the burden should rest upon the company to prove intentional misuse of such opportunity. It may also be clarified that any disclosed opportunities will be permitted under certain exceptional circumstances such as those that result in indirect interest to the director beyond their control. Lastly, the Act may be amended to authorise companies to renounce interest in corporate opportunities, whether broadly or for specific classes or categories, without displacing other duties such as confidentiality, non-use of corporate assets, and fair competition. Such ex-ante allocation of opportunities may minimise subsequent conflicts and facilitate efficient allocation of opportunities.
Contractual Protection
While legislative reforms may take time, contractual protections offer an immediate and practical means of mitigating certain corporate opportunity conflicts beyond the statutory requirements.
Since the obligation under Section 166 binds only the nominee director and not the Investor nominating such director, no statutory restriction prevents the Investor from pursuing competing investments. However, without contractual certainty, disputes may arise over the Investor’s competing activities, particularly where information flows through its nominee director. To preempt such disputes and to secure the Investor’s right to operate across competing portfolio companies, the transaction documents could expressly permit the Investor to invest in competing businesses. However, any such consent applicable to the Investor may not waive or modify the statutory duties of any director nominated by such Investor under Section 166(4). Accordingly, the Investor nominated directors must continue to comply with their obligations under Section 166, independently of any Investor-level consent. To avoid disincentivising investments, the transaction documents may also provide a mechanism to resolve conflicts within a specified timeframe.
For the company’s protection, the transaction documents may include (i) specifying the granularity of disclosures required from nominee directors beyond the statutory minimum disclosure requirements; (ii) imposing strict confidentiality obligations; (iii) maintaining information firewalls; (iv) restricting nominee directors from sharing any competing business opportunities with the relevant Investor; (v) requiring the director to provide any relevant business opportunity first to the company before taking it to the Investor; and (vi) prohibiting the Investor from nominating the same individual as director or board observer to the company and any competing portfolio company simultaneously. Contractual remedies for breaches, including disgorgement of profits derived from the diverted opportunity and suspension of the right to nominate a director, may also be included.
Conclusion
India’s approach towards the corporate opportunity doctrine requires additional legislative clarity and, until then, contractual innovation to protect against conflicting interests and prevent misuse of business opportunities may be considered. A combination of statutory reform introducing structured disclosure mechanisms, ex ante renunciation provisions, and a clear test supplemented by robust drafting in transaction documents would significantly reduce legal uncertainty.
For further information, please contact:
Mohit Gogia, Partner, Cyril Amarchand Mangaldas
mohit.gogia@cyrilshroff.com
[1] (2006) 6 Comp LJ 74 (Bom).
[2] [2021] SGHC 142.
